Search

Author/Creator Prawitz, Thibaud

1. Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations. (May 2023)

Authors:
Christopoulos, Petros; Prawitz, Thibaud; Hong, Jin-Liern; Lin, Huamao M.; Hernandez, Luis; Jin, Shu; Tan, Min; Proskorovsky, Irina; Lin, Jianchang; Zhang, Pingkuan; Patel, Jyoti D.; Ou, Sai-Hong I.; Thomas, Michael; Stenzinger, Albrecht
Journal:
Lung cancer
Issue:
Volume 179(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy. Issue 4 (7th March 2019)

Authors:
Pinto, Cathy Anne; Tervonen, Tommi; Marsh, Kevin; Lambrelli, Dimitra; Schultze, Anna; Tershakovec, Andrew; Hyacinthe, Johanna; Prawitz, Thibaud; Hammad, Tarek A.
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 28:Issue 4(2019)
Page Start:
443
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search